These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6398430)

  • 21. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
    Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
    Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Coppini M; Ventura E
    Minerva Med; 1984 Mar; 75(9-10):469-74. PubMed ID: 6709223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High weekly intravenous doses of desferrioxamine in porphyria cutanea tarda.
    Rocchi E; Cassanelli M; Ventura E
    Br J Dermatol; 1987 Sep; 117(3):393-6. PubMed ID: 3676087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Porphyria cutanea tarda with hypersideremia: effectiveness of desferrioxamine (Desferal)].
    Beurey J; Weber M; Montet Y; Jeandidier P; Barbier JM
    Arch Belg Dermatol Syphiligr; 1966; 22(4):235-41. PubMed ID: 6005619
    [No Abstract]   [Full Text] [Related]  

  • 26. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
    Doss MO
    Z Hautkr; 1988 Apr; 63(4):282-9. PubMed ID: 3291437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the treatment of porphyria cutanea tarda. Effectiveness of slow subcutaneous desferrioxamine infusion.
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Ventura E
    Liver; 1984 Aug; 4(4):280-4. PubMed ID: 6482687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hydroxychloroquine with or without prednisone in the therapy of porphyria cutaneous tarda and of the associated hepatopathy. Preliminary results of a prospective trial].
    Brambilla L; Bellati G; Ideo G; Ronchi G; Finzi AF
    G Ital Dermatol Venereol; 1983; 118(4):261-6. PubMed ID: 6671700
    [No Abstract]   [Full Text] [Related]  

  • 30. [Successful treatment of haemodialysis-related porphyria cutanea tarda with deferoxamine].
    Pitche P; Corrin E; Wolkenstein P; Revuz J; Bagot M
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):37-9. PubMed ID: 12605155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda.
    Tsega E
    Q J Med; 1987 Nov; 65(247):953-7. PubMed ID: 3455550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Favorable clinical and biological action of iron chelator in 4 cases of porphyria cutanea tarda. Attempts at interpretation].
    Beurey J; Weber M; Gurecki H; Perello R; Vadot J
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(5):644-9. PubMed ID: 5710401
    [No Abstract]   [Full Text] [Related]  

  • 33. Follow-up studies of porphyrin excretion in porphyria cutanea tarda treated with p-aminobenzoic acid.
    de Salamanca RE; Peña ML; Olmos A; Molina C; Ladero JM
    Ann Clin Res; 1980 Dec; 12(6):279-81. PubMed ID: 6972189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
    Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Latent porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (4):64-8. PubMed ID: 2763712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of the treatment of porphyria cutanea tarda on the changes of the urinary porphyrin pattern (determined by high performance liquid chromatography) and histopathological aspects of the liver].
    Cainelli T; Marchesi L; De Padova C; Reseghetti A
    G Ital Dermatol Venereol; 1984; 119(3):171-4. PubMed ID: 6746012
    [No Abstract]   [Full Text] [Related]  

  • 37. High-dose hydroxychloroquine treatment of porphyria cutanea tarda.
    Petersen CS; Thomsen K
    J Am Acad Dermatol; 1992 Apr; 26(4):614-9. PubMed ID: 1597548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of deferoxamine capacity to revert a severe porphyria induced by hexachlorobenzene].
    Wainstok de Calmanovici R; Billi SC; Aldonatti CA; San Martín de Viale LC
    Acta Physiol Pharmacol Latinoam; 1987; 37(4):541-54. PubMed ID: 3274026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of phlebotomy on urinary porphyrin pattern and liver histology in patients with porphyria cutanea tarda.
    Di Padova C; Marchesi L; Cainelli T; Gori G; Podenzani SA; Rovagnati P; Rizzardini M; Cantoni L
    Am J Med Sci; 1983; 285(1):2-12. PubMed ID: 6824014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.
    To-Figueras J; Ozalla D; Mateu CH
    Ann Clin Lab Sci; 2003; 33(3):251-6. PubMed ID: 12956438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.